July 22, 2004

Mother-baby drug to be phased out as single therapy

The Medicines Control Council, has recommended to the Health Ministry that it stop using nevirapine as a single agent in the prevention of mother-to-child-HIV-transmission. Health-e caught up with the Registrar of medicines Precious Matsoso, at the XV International AIDS Conference in Bangkok, Thailand, and asked her why the MCC made the decision.

AIDS needs more young voices Living with AIDS # 182

Young people around the globe are at the heart of the AIDS epidemic. Thirty two percent (12.1 million) of under 25 year-olds are HIV-positive, according to UNAIDS. Despite the disproportionate risks and burdens they face, young people are also the world's best hope in the fight against the epidemic. But voices of youth were still marginal at the 15th International AIDS Conference in Bangkok, Thailand

Mother-baby drug to be phased out as single therapy

AIDS needs more young voices Living with AIDS # 182

Newsletter Subscription